{"acute kidney injury": 2.4, "blood alkaline phosphatase increased": 3.57, "blood creatine phosphokinase increased": 6.15, "blood creatinine increased": 2.46, "cholestasis": 11.36, "death": 3.45, "dermatitis acneiform": 58.13, "diarrhoea": 3.63, "disease progression": 2.01, "drug reaction with eosinophilia and systemic symptoms": 35.68, "ejection fraction decreased": 14.07, "face oedema": 4.43, "general physical health deterioration": 2.52, "hepatic cytolysis": 8.77, "intentional product use issue": 10.89, "metastases to central nervous system": 12.55, "mucosal inflammation": 7.37, "off label use": 2.51, "photosensitivity reaction": 41.64, "rash": 4.85, "rash erythematous": 2.29, "rash maculo-papular": 17.2, "rash papular": 4.63, "renal failure": 3.16, "rhabdomyolysis": 4.96, "skin exfoliation": 3.82, "skin toxicity": 63.08, "stevens-johnson syndrome": 9.33, "stomatitis": 3.42, "toxic skin eruption": 15.82, "transaminases increased": 3.13, "uveitis": 24.21}